Mckesson Corp
NYSE:MCK
Mckesson Corp
Revenue
Mckesson Corp
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mckesson Corp
NYSE:MCK
|
Revenue
$344.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
Cardinal Health Inc
NYSE:CAH
|
Revenue
$222.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Revenue
$12.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Adapthealth Corp
NASDAQ:AHCO
|
Revenue
$3.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Revenue
$6.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
Cencora Inc
NYSE:COR
|
Revenue
$303.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
Mckesson Corp
Revenue Breakdown
Breakdown by Geography
Mckesson Corp
Breakdown by Segments
Mckesson Corp
|
Total Revenue:
309B
USD
|
|
United States Pharmaceutical:
278.7B
USD
|
|
International:
14.1B
USD
|
|
Medical-Surgical Solutions:
11.3B
USD
|
Mckesson Corp
Glance View
McKesson Corporation, with its roots tracing back to 1833, stands as a healthcare titan in the pharmaceutical industry. Founded by John McKesson and Charles Olcott in New York City, the company began its journey as an importer and wholesaler of botanical drugs. McKesson has since evolved into one of the largest healthcare companies in the world, delivering critical logistics and distribution services that underpin the healthcare sector. The company's primary role is that of an intermediary, ensuring that pharmaceutical products and medical supplies make their way efficiently from manufacturers to pharmacies, hospitals, and clinics. This pivotal position places McKesson at the heart of the supply chain, making health products more accessible and affordable across North America and beyond. The operational mechanics of McKesson are a complex yet seamless orchestration of advanced logistics, technology, and customer service. By maintaining a vast network of distribution centers, the corporation processes and ships millions of pharmaceutical products daily, ensuring they are delivered within stringent timeframes. Through its well-oiled logistics system, McKesson earns its revenue mainly from the margins on product sales and the fees it charges for its distribution services. Furthermore, the company has diversified into additional areas like healthcare technology solutions, offering software and automation systems that aid healthcare providers in managing their operations more effectively. In summary, McKesson remains an indispensable player in healthcare, translating logistical prowess into a streamlined flow of pharmaceuticals from production to patient care.
See Also
What is Mckesson Corp's Revenue?
Revenue
344.6B
USD
Based on the financial report for Dec 31, 2024, Mckesson Corp's Revenue amounts to 344.6B USD.
What is Mckesson Corp's Revenue growth rate?
Revenue CAGR 10Y
7%
Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Mckesson Corp have been 10% over the past three years , 9% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet